Formulation, Characterization and in-vitro Evaluation of Famciclovir Loaded Solid Lipid Nanoparticles for Improved Oral Absorption

Main Article Content

Pavan Kumar Rawat
Chandra Kishore Tyagi
Sunil Kumar Shah
Arun Kumar Pandey


Famciclovir loaded Solid Lipid Nanoparticles (SLNs) using triglycerides as solid lipids were successfully prepared using the double emulsion-solvent evaporation technique. Formulation parameters like amount and type of lipid and level of surfactants affected the nanoparticle characters. It was observed that nanoparticle characters like average particle size and distribution, drug content, entrapment efficiency and release pattern were dependent on these formulation variables. The optimized formulations depicted the desired characters of low particle size, in the range of 140-170 nm in case of Glyceryl monostearate (GMS) and glyceryl distearate (GDS) SLNs and 250-340 nm in case of glyceryl behenate (GB) SLNs and entrapment efficiencies in the range of 35-48%. In vitro drug release was extended upto 8 h and the release profile was explained by the Baker-Lonsdale model for spherical particles. Morphological examination by Scanning Electron Microscope (SEM) and Transmission Electron Microscope (TEM) displayed homogenous solid, spherical and non- porous particles. The formulations depicted good redispersibility after lyophilization and presence of residual solvents in the formulations within the prescribed limits suggested suitability of the preparation technique. Freeze- dried formulations were found to be stable in terms of particle size and drug loading even after 6 months of storage at refrigerated conditions.

Famciclovir, solid lipid nanoparticles, bioavailability, release kinetics, etc.

Article Details

How to Cite
Rawat, P. K., Tyagi, C. K., Shah, S. K., & Pandey, A. K. (2020). Formulation, Characterization and in-vitro Evaluation of Famciclovir Loaded Solid Lipid Nanoparticles for Improved Oral Absorption. Journal of Pharmaceutical Research International, 32(29), 1-17.
Original Research Article


Cirelli R, Herne K, McCrary M, Lee P, TyringSK. Famciclovir: Review of clinical efficacy and safety. Antiviral Research. 1996;29(2):141-151.

Hodge RV. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chemistry and Chemotherapy, 1993;4(2):67-84.

Kopecny L, Maggs DJ, LeuteneggerCM. Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease. J Feline Med Surg. 2020;22(6):492-499

Baek JS, ChoCW. Surface modification of solid lipid nanoparticles for oral deli very of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. 2017; 117:132-140.

Małgorzata GM, Michal M. Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies. Materials Science and Engineering C: Materials for Biological Applications. 2016;68:982- 994.

Hamishehkar H, Bahadori MB, Vandghanooni S, et al. Preparation, characterization and anti-proliferative effects of sclareol- loaded solid lipid nanoparticles on A549 human lung epithelial cancer cells. Journal of Drug Delivery Science and Technology. 2018; 45:272-280.

Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):191.

Borg N, Gotharson E, Benfeldt E, Groth L, Stahle L. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: Comparison of the suction blister technique and cutaneous microdialysis. Acta DermVenereol. 1999;79(4):274- 7.

Gill KS, Wood MJ. The clinical pharmacokinetics of famciclovir. Clin Pharmacokinet, 1996;31(1):1-8.

Khadijeh K, Majid S, Katayoun MS, An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: Kojic acid-solid lipid nanoparticles. Artificial cells, nanomedicine, and biotechnology. 2020; 48(1):841–853

Abhijit AD, Mangal SN. Single-step and low-energy method to prepare solid lipid nanoparticles and nanostructured lipid carriers using biocompatible solvents. European Journal of Pharmaceutical Research. 2019;1(1):12-19.

Zhao B, Gu S, Du Y, Shen M, Liu X, Shen Y. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. International Journal of Pharmaceutics. 2018;535(1):164-171.

AldawsariHM, SinghS. Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: Synthesis, characterization and anticancer study. Nanomaterials (Basel). 2020;10(3):510.

Pandey A. Solid lipid nanoparticles: A multidimensional drug delivery system in Nanoscience in Medicine: Springer. 2020;1:249-295.

Raina H, Kaur S, Jindal AB. Development of efavirenz loaded solid lipid nanoparticles: Risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterization. Journal of Drug Delivery Science and Technology. 2017;39:180-191.

Abbasalipourkabir R, Salehzadeh A, Abdullah R. Characterization and stability of nanostructured lipid carriers as drug delivery system. Pakistan Journal of Biological Sciences. 2012;15(3):141-6.

Andalib S, Varshosaz J, Hassanzadeh F, et al. Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design. Advance Biomedical Research. 2012;1:45.

Anantachaisilp S, Smith SM, Treetong A, et al. Chemical and structural investigation of lipid nanoparticles: Drug-lipid interaction and molecular distribution. Nanotechnology. 2010;21(12):125102.

Campos J, Varas-Godoy M, Haidar ZS, et al. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: A proof-of-concept study in breast cancer cells. Nanomedicine (Lond). 2017;12(5):473-490.

Attama AA., Schicke BC, Paepenmuller T, et al. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: Characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2007;67(1):48-57.

Alam M, Najmi AK, Iqbal A, et al. Formulation and evaluation of nano lipid formulation containing CNS acting drug: Molecular docking, in-vitro assessment and bioactivity detail in rats. Artif Cells NanomedBiotechnol. 2018;46(2): 46-57.

Albuquerque J, Moura CC,Sarmento B. et al. Solid lipid nanoparticles: A potential multifunctional approach towards rheumatoid arthritis theranostics. Molecules. 2015;20(6):11103-18.

Algul D, Duman G, Ozdemir S, et al. Preformulation, characterization, and in vitro release studies of caffeine-loaded solid lipid nanoparticles. Journal of Cosmetic Science. 2018;69(3):165-173.

Abdel-Mottaleb MM, Neumann D, Lamprecht A. Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics. 2011;79(1):36-42.

Shaimaa EH, Maii AS, Yasmina A., et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical study. Drug Delivery. 2018;25(1): 78-90.

Zardini AA, Mohebbi M, Farhoosh R, et al. Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification. Journal of Food Science and Technology. 2018;55(1): 287-298.

Alwan AQ, Rassouli A, Fatemeh A, et al. Preparation and characterization of three tilmicosin-loaded lipid nanoparticles: Physicochemical Properties and in-vitroantibacterial activities. Iranian Journal of Pharmaceutical Research. 2016;15(4): 663-676.

Beg S, Saini S, Bandopadhyay S, et al. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. Drug Development and Industrial Pharmacy. 2018;44(3):407-420.

Beg S, Sandhu PS, Batra RS. et al. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Delivery. 2015;22(6): 765-84.

Annu S, Rehman S, Shadab M. et al. Analyzing nanotheraputics-based approaches for the management of psychotic disorders. Journal of Pharmaceutical Sciences. 2019;108(12): 3757-3768.

Alp G, Aydogan N. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer. European Journal of Pharmaceutics and Biopharmaceutics. 2020;149:45-57.

Bunjes H, Koch MH, Westesen K. et al. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. Journal of Pharmaceutical Sciences, 2003;92(7):1509-20.

Chen CC, Tsai TH, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetic. European Journal of Pharmaceutics and Biopharmaceutics. 2010;74(3):474-82.

Dongfei L, Yifan G, Yuan Y. et al. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: Preparation, characterization and in vitro studies. Journal of Microencapsulation. 2010;27(8):726-34.

Xiaoya L, Chenglin Y, Zhu Y. et al. Pickering emulsions stabilized by self-assembled colloidal particles of copolymers of P(St-alt-MAn)-co-P (VM-alt-MAn). Journal of Colloid & Interface Science. 2010;351(2):315- 22.